後天性血栓傾向 特に抗リン脂質抗体症候群の血栓機序について
Saved in:
| Published in | 臨床化学 Vol. 35; no. 2; pp. 119 - 128 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本臨床化学会
28.04.2006
|
| Online Access | Get full text |
| ISSN | 0370-5633 2187-4077 |
| DOI | 10.14921/jscc1971b.35.2_119 |
Cover
| Author | 吉田, 美香 内藤, 澄悦 垂水, 隆志 家子, 正裕 小池, 隆夫 中林, 透 渥美, 達也 |
|---|---|
| Author_xml | – sequence: 1 fullname: 家子, 正裕 organization: 北海道大学大学院分子病態制御学講座(第二内科) – sequence: 1 fullname: 内藤, 澄悦 organization: 北海道医療大学臨床検査部 – sequence: 1 fullname: 垂水, 隆志 organization: 北海道医療大学歯学部内科 – sequence: 1 fullname: 吉田, 美香 organization: 北海道医療大学臨床検査部 – sequence: 1 fullname: 渥美, 達也 organization: 北海道大学大学院分子病態制御学講座(第二内科) – sequence: 1 fullname: 小池, 隆夫 organization: 北海道大学大学院分子病態制御学講座(第二内科) – sequence: 1 fullname: 中林, 透 organization: 北海道医療大学歯学部内科 |
| BookMark | eNo9j71KA0EURgeJ4BpTWvkMu86d_yll8ScQsEk_3L3O6C4xym4au2BtofgCCoL4EnmbDT6GESXN9xUHDpx9NpjfzSNjR8ALUF7AcdMRgbdQFVIXIgD4HZYJcDZX3NoBy7i0PNdGyj026rq64lxxDt64jB32q6f-42u9_Px-X67fXvvHVf_8csB2E866OPr_IZuenU7Li3xyeT4uTyZ54xTmhIaMhailSmBJJ3JIPpICqUAkFJCkRh4TVYY7bvmGV-C8w0jRmis5ZOWftukWeB3DfVvfYvsQsF3UNIthGxakDuJ3Nm1bSjfYhgblD6aRUps |
| ContentType | Journal Article |
| Copyright | 日本臨床化学会 |
| Copyright_xml | – notice: 日本臨床化学会 |
| DOI | 10.14921/jscc1971b.35.2_119 |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2187-4077 |
| EndPage | 128 |
| ExternalDocumentID | article_jscc1971b_35_2_35_119_article_char_ja |
| GroupedDBID | --- ALMA_UNASSIGNED_HOLDINGS JSF KQ8 OK1 RJT |
| ID | FETCH-LOGICAL-j84a-ca6c671e534f17c5fc8ac9ec413412fa21f35a0efcb608070c8ab1898aece76d3 |
| ISSN | 0370-5633 |
| IngestDate | Wed Sep 03 06:29:46 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 2 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j84a-ca6c671e534f17c5fc8ac9ec413412fa21f35a0efcb608070c8ab1898aece76d3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jscc1971b/35/2/35_119/_article/-char/ja |
| PageCount | 10 |
| ParticipantIDs | jstage_primary_article_jscc1971b_35_2_35_119_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2006/04/28 |
| PublicationDateYYYYMMDD | 2006-04-28 |
| PublicationDate_xml | – month: 04 year: 2006 text: 2006/04/28 day: 28 |
| PublicationDecade | 2000 |
| PublicationTitle | 臨床化学 |
| PublicationTitleAlternate | 臨床化学 |
| PublicationYear | 2006 |
| Publisher | 一般社団法人 日本臨床化学会 |
| Publisher_xml | – name: 一般社団法人 日本臨床化学会 |
| References | 3) Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, Caen J: Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation, Thromb Haemost, 60: 54-58, 1988. 30) Biemond BJ, Friederich PW, Koschinsky ML, Levi M, Sangrar W, Xia J, Buller HR, ten Cate JW: Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo, Circulation, 96: 1612-1615, 1997. 8) 武田美香, 家子正裕, 内藤澄悦, 垂水隆志, 中林透, 荒井滋朗, 渥美達也, 小池隆夫: 抗リン脂質抗体症候群における線溶活性の低下に関する検討, 日本検査血液学会雑誌, 4: 398-405, 2003. 21) Sironi L, Mussoni L, Prati L, Baldassarre D, Camera M, Banfi C, Tremoli E: Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL, Arterioscler Thromb Vasc Biol, 16: 89-96, 1996. 29) Miyata M, Biro S, Kaieda H, Tanaka H: Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways, FEBS Lett, 37T 493-496, 1995. 15) Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes, J Clin Invest, 96: 1395-1403, 1995. 16) Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL: Platelet dysfunction in type 2 diabetes, Diabetes Care, 24: 1476-1485, 2001. 27) Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities, Circulation, 94: 2057-2063, 1996. 14) 大森啓造, 野出孝一: 糖代謝異常と血栓形成のメカニズム, a血管壁の異常から, 血栓と循環, 11: 92-96, 2003. 33) Salgado A, Boveda JL, Monasterio J, Segura RM, Mourelle M, Gomez-Jimenez J, Peracaula R: Inflammatory mediators and their influence on haemostasis, Haemostasis, 24: 132-138, 1994. 17) 池本卓, 阿久津寿江, 赤司俊彦, 田懊尚子: 糖代謝異常と血栓形成のメカニズム, b血液成分の異常から, 血栓と循環, 11: 97-102, 2003. 10) Itoh Y, Inuzuka K, Kohno I, Wada H, Shiku H, Ohkura N, Kato H: Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V, J Biochem (Tokyo), 128: 1017-1024, 2000. 32) Sase T, Wada H, Nishioka J, Abe Y, Gabazza EC, Shiku H, Suzuki K, Nakamura S, Nobori T: Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases, Thromb Haemost, 89: 660-665, 2003. 4) Malia RG, Kitchen S, Greaves M, Preston FE: Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies, Br J Haematol, 76: 101-107, 1990. 6) Ieko M, Nakabayashi T, Takeda M, Naitoh S, Atsumi T, Koike T: The inhibition of protein C anticoagulant activity by anti-β 2-glycoprotein I (β 2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods, Mod Rheumatol, 12: 44-49, 2002. 24) Block LH, Knorr M, Vogt E, Locher R, Vetter W, Groscurth P, Qiao BY, Pometta D, James R, Regenass M, Pletscher A: Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism, Proc Natl Acad Sci U S A, 85: 885-889, 1988. 28) Halle M, Berg A, Keul J, Baumstark MW: Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men, Arterioscler Thromb Vasc Biol, 16: 144-148, 1996. 7) Jurado M, Paramo JA, Gutierrez-Pimentel M, Rocha E: Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders, Thromb Haemost, 68: 516-520, 1992. 13) Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G, Meroni PL: Relationship between anti-phospholipid and antiendothelial cell antibodies IIP. beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules, Clin Exp Rheumatol, 13: 179-185, 1995. 31) Anderson S, Komers R, Brenner BM: Renal and Sytemic Manifestations of Glomerular disease (in The Kidney, eds Brenner BM), p.1927-1954, SANDERS, Philadelphia, 2004. 9) Takeuchi R, Atsumi T, Ieko M, Amasaki Y, Ichikawa K, Koike T: Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome, Br J Haematol, 119: 781-788, 2002. 18) Hafer-Macko CE, Ivey FM, Gyure KA, Sorkin JD, Macko RF: Thrombomodulin deficiency in human diabetic nerve microvasculature, Diabetes, 51: 1957-1963, 2002. 23) Beitz J, Block HU, Beitz A, Muller G, Winkler L, Dargel R, Mest HJ: Endogenous lipoproteins modify the thromboxane formation capacity of platelets, Atherosclerosis, 60: 95-99, 1986. 2) 内藤澄悦, 家子正裕, 武田美香, 渥美達也, 小池隆夫: 抗リン脂質抗体症候群におけるトロンビン・アンチトロンビン (TAT) 複合体の形成阻害とF1+2/TAT比の有用性, 臨床病理, 48: 540-546, 2000. 5) Ieko M, Ichikawa K, Triplett DA, Matsuura E, Atsumi T, Sawada K, Koike T: Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies, Arthritis Rheum, 42: 167-174, 1999. 12) Amengual O, Atsumi T, Khamashta MA, Hughes GR: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome, Thromb Haemost, 79: 276-281, 1998. 26) Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison JV, Fox TE, Walker AO: Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor, Atherosclerosis, 78: 19-24, 1989. 34) Furlan M, Robles R, Solenthaler M, Lammle B: Acquired deficiency of von Willebrand factorcleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91: 2839-2846, 1998. 25) Nofer JR, Noll C, Feuerborn R, Assmann G, Tepel M: Low density lipoproteins inhibit the Na(+)/H(+) antiport in human platelets via activation of p38(MAP) kinase, Biochem Biophys Res Commun, 340: 751-757, 2006. 19) Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D' Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study, JAMA, 283: 221-228, 2000. 11) Yasuda S, Atsumi T, Ieko M, Matsuura E, Kobayashi K, Inagaki J, Kato H, Tanaka H, Yamakado M, Akino M, Saitou H, Amasaki Y, Jodo S, Amengual O, Koike T: Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis, Blood, 103: 3766-3772, 2004. 20) 丸山征郎: 動脈硬化症の発症・進展と血栓形成, aプラーク形成における血栓形成の意義, 血栓と循環, 9: 10-12, 2001. 22) Ishii H, Kizaki K, Horie S, Kazama M: Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes, J Biol Chem, 271: 8458-8465, 1996. 1) Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop, Arthritis Rheum, 42: 1309-1311, 1999. |
| References_xml | – reference: 3) Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, Caen J: Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation, Thromb Haemost, 60: 54-58, 1988. – reference: 5) Ieko M, Ichikawa K, Triplett DA, Matsuura E, Atsumi T, Sawada K, Koike T: Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies, Arthritis Rheum, 42: 167-174, 1999. – reference: 21) Sironi L, Mussoni L, Prati L, Baldassarre D, Camera M, Banfi C, Tremoli E: Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL, Arterioscler Thromb Vasc Biol, 16: 89-96, 1996. – reference: 2) 内藤澄悦, 家子正裕, 武田美香, 渥美達也, 小池隆夫: 抗リン脂質抗体症候群におけるトロンビン・アンチトロンビン (TAT) 複合体の形成阻害とF1+2/TAT比の有用性, 臨床病理, 48: 540-546, 2000. – reference: 27) Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities, Circulation, 94: 2057-2063, 1996. – reference: 8) 武田美香, 家子正裕, 内藤澄悦, 垂水隆志, 中林透, 荒井滋朗, 渥美達也, 小池隆夫: 抗リン脂質抗体症候群における線溶活性の低下に関する検討, 日本検査血液学会雑誌, 4: 398-405, 2003. – reference: 4) Malia RG, Kitchen S, Greaves M, Preston FE: Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies, Br J Haematol, 76: 101-107, 1990. – reference: 7) Jurado M, Paramo JA, Gutierrez-Pimentel M, Rocha E: Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders, Thromb Haemost, 68: 516-520, 1992. – reference: 23) Beitz J, Block HU, Beitz A, Muller G, Winkler L, Dargel R, Mest HJ: Endogenous lipoproteins modify the thromboxane formation capacity of platelets, Atherosclerosis, 60: 95-99, 1986. – reference: 14) 大森啓造, 野出孝一: 糖代謝異常と血栓形成のメカニズム, a血管壁の異常から, 血栓と循環, 11: 92-96, 2003. – reference: 13) Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G, Meroni PL: Relationship between anti-phospholipid and antiendothelial cell antibodies IIP. beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules, Clin Exp Rheumatol, 13: 179-185, 1995. – reference: 19) Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D' Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study, JAMA, 283: 221-228, 2000. – reference: 29) Miyata M, Biro S, Kaieda H, Tanaka H: Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways, FEBS Lett, 37T 493-496, 1995. – reference: 18) Hafer-Macko CE, Ivey FM, Gyure KA, Sorkin JD, Macko RF: Thrombomodulin deficiency in human diabetic nerve microvasculature, Diabetes, 51: 1957-1963, 2002. – reference: 33) Salgado A, Boveda JL, Monasterio J, Segura RM, Mourelle M, Gomez-Jimenez J, Peracaula R: Inflammatory mediators and their influence on haemostasis, Haemostasis, 24: 132-138, 1994. – reference: 31) Anderson S, Komers R, Brenner BM: Renal and Sytemic Manifestations of Glomerular disease (in The Kidney, eds Brenner BM), p.1927-1954, SANDERS, Philadelphia, 2004. – reference: 24) Block LH, Knorr M, Vogt E, Locher R, Vetter W, Groscurth P, Qiao BY, Pometta D, James R, Regenass M, Pletscher A: Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism, Proc Natl Acad Sci U S A, 85: 885-889, 1988. – reference: 16) Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL: Platelet dysfunction in type 2 diabetes, Diabetes Care, 24: 1476-1485, 2001. – reference: 10) Itoh Y, Inuzuka K, Kohno I, Wada H, Shiku H, Ohkura N, Kato H: Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V, J Biochem (Tokyo), 128: 1017-1024, 2000. – reference: 34) Furlan M, Robles R, Solenthaler M, Lammle B: Acquired deficiency of von Willebrand factorcleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91: 2839-2846, 1998. – reference: 30) Biemond BJ, Friederich PW, Koschinsky ML, Levi M, Sangrar W, Xia J, Buller HR, ten Cate JW: Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo, Circulation, 96: 1612-1615, 1997. – reference: 17) 池本卓, 阿久津寿江, 赤司俊彦, 田懊尚子: 糖代謝異常と血栓形成のメカニズム, b血液成分の異常から, 血栓と循環, 11: 97-102, 2003. – reference: 6) Ieko M, Nakabayashi T, Takeda M, Naitoh S, Atsumi T, Koike T: The inhibition of protein C anticoagulant activity by anti-β 2-glycoprotein I (β 2GPI) antibodies isolated from patients with antiphospholipid syndrome by chromatography methods, Mod Rheumatol, 12: 44-49, 2002. – reference: 26) Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison JV, Fox TE, Walker AO: Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor, Atherosclerosis, 78: 19-24, 1989. – reference: 12) Amengual O, Atsumi T, Khamashta MA, Hughes GR: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome, Thromb Haemost, 79: 276-281, 1998. – reference: 9) Takeuchi R, Atsumi T, Ieko M, Amasaki Y, Ichikawa K, Koike T: Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome, Br J Haematol, 119: 781-788, 2002. – reference: 25) Nofer JR, Noll C, Feuerborn R, Assmann G, Tepel M: Low density lipoproteins inhibit the Na(+)/H(+) antiport in human platelets via activation of p38(MAP) kinase, Biochem Biophys Res Commun, 340: 751-757, 2006. – reference: 28) Halle M, Berg A, Keul J, Baumstark MW: Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men, Arterioscler Thromb Vasc Biol, 16: 144-148, 1996. – reference: 32) Sase T, Wada H, Nishioka J, Abe Y, Gabazza EC, Shiku H, Suzuki K, Nakamura S, Nobori T: Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases, Thromb Haemost, 89: 660-665, 2003. – reference: 11) Yasuda S, Atsumi T, Ieko M, Matsuura E, Kobayashi K, Inagaki J, Kato H, Tanaka H, Yamakado M, Akino M, Saitou H, Amasaki Y, Jodo S, Amengual O, Koike T: Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis, Blood, 103: 3766-3772, 2004. – reference: 15) Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes, J Clin Invest, 96: 1395-1403, 1995. – reference: 20) 丸山征郎: 動脈硬化症の発症・進展と血栓形成, aプラーク形成における血栓形成の意義, 血栓と循環, 9: 10-12, 2001. – reference: 22) Ishii H, Kizaki K, Horie S, Kazama M: Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes, J Biol Chem, 271: 8458-8465, 1996. – reference: 1) Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop, Arthritis Rheum, 42: 1309-1311, 1999. |
| SSID | ssib004001968 ssib058494216 ssj0003236072 |
| Score | 1.676203 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 119 |
| Subtitle | 特に抗リン脂質抗体症候群の血栓機序について |
| Title | 後天性血栓傾向 |
| URI | https://www.jstage.jst.go.jp/article/jscc1971b/35/2/35_119/_article/-char/ja |
| Volume | 35 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 臨床化学, 2006/04/28, Vol.35(2), pp.119-128 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NihQxEG7W9eJFFFf8Zw_m2GOSTucHvGTGXhZFQRhhD0LTnU4Oc1hFZy-eFs8eFF9AQRBfYt9mFh_DqnR67HUFXYUhhMpX1VWp7k6lJ6lk2d2O0ybAvZC7zvFc-I7mRgeWu4bzhrvSh4Cbkx8_kbvPxMO9cm_j3PPRqqWDZTtxb367r-RfvAo08Cvukj2DZ9dCgQB18C-U4GEo_8rHpCrJtCJ6hhUriDWkkrh2wSpSaWIZ1oFiKTEFYjRHPFQMUNg4MEW8VsTqKNMSbSN-RoyMwh8Qu_6GFwkVmQ4tIAwcFS8EsCJeuiD9qZYDXoNeJbYYhZomPCovos78F_mmQhpCKJkmvCHGoiDUcIcYdQJPiQbrFTECWSJeRfkVMlpJ-hOSxl84xLBjHO9JUgGjjh0GJVgwQwGgauqwabQM9EHLItjCL1qBJpWxMotsf-7JyA8UO3oPF4rmpezzdUx8pEFgpGDqnU6gSQNJn3clPTB8NCqwNCr0AQbrbTs1dgnD4-D12jlmFGsnRTnh9Zr3RFLwdMvVa3BdlDXHAvD10Iob9-oFzB7Oc6XiIoZHT_X47c1GmZEgEjViyOSEcUzBC0lV_zdc6oGUtgs1vXdaTwjiFjClGZZDxghtfim7mKZW27ZX63K2sWiuZFuro3erL9-OD79-_3x4_Onj6u3R6v2HrWy-U81nu3k6CiRfaNHAm0M6qZgvCxGYcrjusHHGO4HpCHloOAtF2VAfXCthCqQotLdMG91455XsiqvZ5v6LfX8t26bKG8d8x2TjRTDBUN_J0gQZ2tBBNHc9u98bUb_s073UZ-rrG__HfjO78PMJuJVtLl8d-NsQ9S7bO9F5PwDDtn_7 |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%BE%8C%E5%A4%A9%E6%80%A7%E8%A1%80%E6%A0%93%E5%82%BE%E5%90%91&rft.jtitle=%E8%87%A8%E5%BA%8A%E5%8C%96%E5%AD%A6&rft.au=%E5%AE%B6%E5%AD%90%2C+%E6%AD%A3%E8%A3%95&rft.au=%E5%86%85%E8%97%A4%2C+%E6%BE%84%E6%82%A6&rft.au=%E5%9E%82%E6%B0%B4%2C+%E9%9A%86%E5%BF%97&rft.au=%E5%90%89%E7%94%B0%2C+%E7%BE%8E%E9%A6%99&rft.date=2006-04-28&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%87%A8%E5%BA%8A%E5%8C%96%E5%AD%A6%E4%BC%9A&rft.issn=0370-5633&rft.eissn=2187-4077&rft.volume=35&rft.issue=2&rft.spage=119&rft.epage=128&rft_id=info:doi/10.14921%2Fjscc1971b.35.2_119&rft.externalDocID=article_jscc1971b_35_2_35_119_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0370-5633&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0370-5633&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0370-5633&client=summon |